Header Logo

Connection

Michael Gottlieb to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Michael Gottlieb has written about Antibodies, Monoclonal, Humanized.
Michael Gottlieb
Connection Strength
0.530
Antibodies, Monoclonal, Humanized
  1. Idarucizumab for the Reversal of Dabigatran. Ann Emerg Med. 2017 May; 69(5):554-558.
    View in: PubMed
    Score: 0.530
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.